NCT04932525 2026-02-06
STING
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
Clinical Trials
8 trialsNCT06470971 2026-01-20
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT05267912 2025-12-16
ORGANOTREAT
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Active not recruiting
NCT01573780 2022-08-15
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Terminated
NCT01450384 2016-02-23
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
Virginia Commonwealth University
Phase 1 Completed
NCT00423865 2015-05-25
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00483457 2012-09-03
Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients
Vanderbilt-Ingram Cancer Center
Completed
NCT00368914 2010-08-09
Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed